TG - Tredegar Corporation
Connor Clark and Lunn Investment Management Ltd. bought a new stake in Tredegar Corporation (NYSE: TG) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 98,400 shares of the basic materials company's stock, valued at approximately $783,000. Connor Clark
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES ELECTION OF ANA DUTRA TO BOARD OF DIRECTORS.
TG's Q2 earnings per share and sales improve year over year as Aluminum Extrusions benefit from favorable metal dynamics and rising TSLOTS demand, offsetting softer volumes and weaker High Performance Films EBITDA.
Tredegar Corporation (NYSE: TG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $8.29 and traded as high as $8.39. Tredegar shares last traded at $7.8570, with a volume of 302,646 shares trading hands. Analyst Ratings Changes Separately, Weiss Ratings
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR PLANS TO RELEASE SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 7, 2026.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES THE RETIREMENT OF FRASIER W. BRICKHOUSE II, CHIEF FINANCIAL OFFICER, TREASURER AND VICE PRESIDENT, EFFECTIVE SEPTEMBER 1, 2026.
[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of pl
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZAÂ (olezarsen) a
NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / Trifecta Gold Ltd. (TSXV:TG)(OTCQB:TRRFF) ("Trifecta" or the "Company") announces that further to its news release dated June 15, 2026, the Company has increased its previously announced Private Placement of Flow-through shares to consist of the sale of up to 5,750,000 Flow-through shares at a price of $0.20 per Flow-through share.
Grafton Group LON: GFTU outlined a five-year growth plan at its Capital Markets Event, with management emphasizing the company's European distribution platform, cash generation and acquisition strategy as key drivers of shareholder value through 2030.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Bonnell Leadership Changes.
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Director Transitions.
RICHMOND, Va.--(BUSINESS WIRE)--SUSAN SWEENEY JOINS TREDEGAR AS VICE PRESIDENT AND CHIEF HUMAN RESOURCES OFFICER.
[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today presented new positive clinical data for plozasiran supporting its use in patients with moder
Tredegar posts a sharp year-over-year increase in Q1 earnings per share as pricing gains and stronger aluminum extrusion margins offset softer demand and weakness in High Performance Films.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS FIRST QUARTER 2026 RESULTS.
TG reports a year-over-year increase in Q4 earnings per share and revenues, driven by Aluminum Extrusions, though weakness in High Performance Films and tariff pressures weigh on overall performance.
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS.